Treatment Evolution in Acute Lymphoblastic Leukemia

Course Director, Daniel J. DeAngelo, MD, PhD, discusses acute lymphoblastic leukemia in this CME activity titled Treatment Evolution in Acute Lymphoblastic Leukemia: Insight on Novel Antibody Technologies and Immunotherapy Advances. For the full presentation, downloadable practice aids and slides, complete CME information, and to apply for credit, please visit us at http://www.peerviewpress.com/KCD865. CME credit will be available until December 27, 2017.